Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Boron Gluconate
2. D-gluconate
3. D-gluconic Acid
4. Dextronic Acid
5. Gluconate
6. Gluconic Acid
7. Gluconic Acid, (113)indium-labeled
8. Gluconic Acid, (14)c-labeled
9. Gluconic Acid, (159)dysprosium-labeled Salt
10. Gluconic Acid, (99)technecium (5+) Salt
11. Gluconic Acid, 1-(14)c-labeled
12. Gluconic Acid, 6-(14)c-labeled
13. Gluconic Acid, Aluminum (3:1) Salt
14. Gluconic Acid, Ammonium Salt
15. Gluconic Acid, Calcium Salt
16. Gluconic Acid, Cesium(+3) Salt
17. Gluconic Acid, Cobalt (2:1) Salt
18. Gluconic Acid, Copper Salt
19. Gluconic Acid, Fe(+2) Salt, Dihydrate
20. Gluconic Acid, Lanthanum(+3) Salt
21. Gluconic Acid, Magnesium (2:1) Salt
22. Gluconic Acid, Manganese (2:1) Salt
23. Gluconic Acid, Monolithium Salt
24. Gluconic Acid, Monopotassium Salt
25. Gluconic Acid, Monosodium Salt
26. Gluconic Acid, Potassium Salt
27. Gluconic Acid, Strontium (2:1) Salt
28. Gluconic Acid, Tin(+2) Salt
29. Gluconic Acid, Zinc Salt
30. Lithium Gluconate
31. Magnerot
32. Magnesium Gluconate
33. Maltonic Acid
34. Manganese Gluconate
35. Pentahydroxycaproic Acid
36. Sodium Gluconate
37. Zinc Gluconate
1. Sodium Galactonate
2. D-gluconic Acid Sodium Salt;sodium D-gluconate;d-gluconate Sodium Salt
3. Schembl23641
4. Bcp13391
5. Akos026749890
6. Sb45452
7. Sodium Gluconate 45% (technical Grade)
8. Ft-0626723
9. Gluconate Sodium;d-gluconic Acid Sodium Salt; Sodium D-gluconate; D-gluconate Sodium Salt
| Molecular Weight | 218.14 g/mol |
|---|---|
| Molecular Formula | C6H11NaO7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 218.04024697 g/mol |
| Monoisotopic Mass | 218.04024697 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 176 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Topical
Fillers, Diluents & Binders
Thickeners and Stabilizers
Controlled & Modified Release
Lubricants & Glidants
Taste Masking
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A potassium 2,3,4,5,6-pentahydroxyhexanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of potassium 2,3,4,5,6-pentahydroxyhexanoate, including repackagers and relabelers. The FDA regulates potassium 2,3,4,5,6-pentahydroxyhexanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. potassium 2,3,4,5,6-pentahydroxyhexanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of potassium 2,3,4,5,6-pentahydroxyhexanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A potassium 2,3,4,5,6-pentahydroxyhexanoate supplier is an individual or a company that provides potassium 2,3,4,5,6-pentahydroxyhexanoate active pharmaceutical ingredient (API) or potassium 2,3,4,5,6-pentahydroxyhexanoate finished formulations upon request. The potassium 2,3,4,5,6-pentahydroxyhexanoate suppliers may include potassium 2,3,4,5,6-pentahydroxyhexanoate API manufacturers, exporters, distributors and traders.
click here to find a list of potassium 2,3,4,5,6-pentahydroxyhexanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A potassium 2,3,4,5,6-pentahydroxyhexanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of potassium 2,3,4,5,6-pentahydroxyhexanoate active pharmaceutical ingredient (API) in detail. Different forms of potassium 2,3,4,5,6-pentahydroxyhexanoate DMFs exist exist since differing nations have different regulations, such as potassium 2,3,4,5,6-pentahydroxyhexanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A potassium 2,3,4,5,6-pentahydroxyhexanoate DMF submitted to regulatory agencies in the US is known as a USDMF. potassium 2,3,4,5,6-pentahydroxyhexanoate USDMF includes data on potassium 2,3,4,5,6-pentahydroxyhexanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The potassium 2,3,4,5,6-pentahydroxyhexanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of potassium 2,3,4,5,6-pentahydroxyhexanoate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a potassium 2,3,4,5,6-pentahydroxyhexanoate Drug Master File in Korea (potassium 2,3,4,5,6-pentahydroxyhexanoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of potassium 2,3,4,5,6-pentahydroxyhexanoate. The MFDS reviews the potassium 2,3,4,5,6-pentahydroxyhexanoate KDMF as part of the drug registration process and uses the information provided in the potassium 2,3,4,5,6-pentahydroxyhexanoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a potassium 2,3,4,5,6-pentahydroxyhexanoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their potassium 2,3,4,5,6-pentahydroxyhexanoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of potassium 2,3,4,5,6-pentahydroxyhexanoate suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing potassium 2,3,4,5,6-pentahydroxyhexanoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for potassium 2,3,4,5,6-pentahydroxyhexanoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture potassium 2,3,4,5,6-pentahydroxyhexanoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain potassium 2,3,4,5,6-pentahydroxyhexanoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a potassium 2,3,4,5,6-pentahydroxyhexanoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of potassium 2,3,4,5,6-pentahydroxyhexanoate suppliers with NDC on PharmaCompass.
potassium 2,3,4,5,6-pentahydroxyhexanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of potassium 2,3,4,5,6-pentahydroxyhexanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right potassium 2,3,4,5,6-pentahydroxyhexanoate GMP manufacturer or potassium 2,3,4,5,6-pentahydroxyhexanoate GMP API supplier for your needs.
A potassium 2,3,4,5,6-pentahydroxyhexanoate CoA (Certificate of Analysis) is a formal document that attests to potassium 2,3,4,5,6-pentahydroxyhexanoate's compliance with potassium 2,3,4,5,6-pentahydroxyhexanoate specifications and serves as a tool for batch-level quality control.
potassium 2,3,4,5,6-pentahydroxyhexanoate CoA mostly includes findings from lab analyses of a specific batch. For each potassium 2,3,4,5,6-pentahydroxyhexanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
potassium 2,3,4,5,6-pentahydroxyhexanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (potassium 2,3,4,5,6-pentahydroxyhexanoate EP), potassium 2,3,4,5,6-pentahydroxyhexanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (potassium 2,3,4,5,6-pentahydroxyhexanoate USP).
LOOKING FOR A SUPPLIER?
